XIAP overexpressing inflammatory breast cancer patients have high infiltration of immunosuppressive subsets and increased TNFR1 signaling targetable with Birinapant
Source
Translational oncology - ISSN 1936-5233-43 (2024) p. 1-13
The immune microenvironment characterisation and dynamics in hormone receptor-positive breast cancer before and after neoadjuvant endocrine therapy
Source
Cancer Medicine - ISSN 2045-7634-12:17 (2023) p. 17901-17913
The evolution and prognostic role of tumour-infiltrating lymphocytes and peripheral blood-based biomarkers in inflammatory breast cancer patients treated with neoadjuvant chemotherapy
Source
Cancers - ISSN 2072-6694-13:18 (2021) p.
Immune landscape of inflammatory breast cancer suggests vulnerability to immune checkpoint inhibitors
Source
Oncoimmunology - ISSN 2162-402X-10:1 (2021) p.
The immunologic aspects in hormone receptor positive breast cancer
Source
Cancer Treatment and Research Communications - ISSN 2468-2942-25 (2020) p.